Objective: The present study is aimed to develop and validate an Ultra-Fast Liquid Chromatography-Diode Array Detector (UFLC-DAD) method for the quantification of vitamin K2 as Menaquinone-4 (MK-4) in rabbit plasma. Method: Standard solutions and spiked plasma samples of MK-4 and Internal Standard (IS) were prepared from primary stock solutions of 1mg/ ml concentration in ethanol each. Protein precipitation was carried out for the MK-4 and IS extraction from plasma spiked samples. Chromatographic separation was employed using Isopropyl Alcohol and Acetonitrile (50:50 v/v) as mobile phase and a C-18 column with 1ml/min flow rate and a run time of 10 mins. Detection was carried out in the range 190-600 nm with 269 nm set as a reference wavelength. Result: The retention times of MK-4 and IS were at 5.5 ± 0.5 mins and 8 ± 0.5 mins respectively. Calibration curve for MK-4 was found to be linear in the range of 0.374 to 6 µg/ ml with an R 2 value of 0.9934. The % RSD for accuracy was <15%, inter and intraday precisions were <10%. The samples were found to be stable throughout the study. Conclusion: This method can be applied to the estimation of MK-4 in rabbit plasma using UFLC-DAD.
INTRODUCTION
There is expanding enthusiasm for the potential medical advantages of vitamin K past its part in coagulation. A few examinations have announced capacities for vitamin K past its established part, including the change of bone health, 1 also, the diminishment of vascular calcification and cardiovascular risk. 2, 3 Besides, a few studies [2] [3] [4] have proposed that menaquinones, otherwise called vitamin K 2 , could be more potent in these capacities than Phylloquinone, otherwise called vitamin K 1 . Menaquinones, generally found in nature, have side chains of fluctuating length in the vicinity of four and thirteen isoprene units, the vast majority of which are unsaturated. 5 MK-4 is extraordinary among the menaquinones in that microscopic organisms do not orchestrate it. Instead, MK-4 is alkylated from menadione (Vitamin K 3 ), a manufactured type of vitamin K that is available in animal feeds or is the result of tissuespecific transformation specifically from dietary phylloquinone, with menadione as the hypothesized intermediate. 6, 7 There is additionally a theory that more extended chain menaquinones, for example, MK-7, can be changed over to MK-4 as well. 8 The most bounteous menaquinones in the human eating regimen are the short chain MK-4, originates from animal products and the long-chain MK-7, MK-8, MK-9 and MK-10. All types of vitamin K have one open capacity. They are all filled in as a cofactor for the post-translational enzyme gamma-glutamyl carboxylase, which is set up by the basic naphthoquinone ring structure. 9 This catalyst changes over particular protein-bound glutamate deposits into gamma-carboxyglutamate, by and large, known as Gla. Presently, seventeen individuals from the Gla protein family are known, incorporating seven proteins associated with blood coagulation (All combined in the liver), Osteocalcin (OC; bone), Matrix Gla Protein (MGP; for the most part ligament and vessel wall), growth arrest-specific protein 6, Gla-rich proteins, periostin and periostin-like factor. 10 Aside from the thickening elements OC (Bone arrangement) and MGP (Inhibitor of delicate tissue calcification), the physiological significance of these proteins is not yet completely understood. 10 Amidst all the above benign effects of menaquinone-4, the necessity to develop a simple, accurate and reliable method for analysis of menaquinone-4 in biological samples is essential and also is the aim of our study.
MATERIALS AND METHODS

Chemicals and reagents
Reference standards Vitamin K 2 (Menaquinone-4) was purchased from Sigma Aldrich, (Bangalore) India and Vitamin K 1 (IS) was purchased from SUPELCO, (Bellefonte) in the USA. The structures of these compounds are shown in Figures 1 and 2 respectively. Solvents HPLC Grade Solvent Acetonitrile was purchased from Merck, (Mumbai, India). Isopropyl alcohol AR grade was purchased from Qualigens fine chemicals (Mumbai, India). Milli-Q-water for HPLC analysis and extraction was obtained using a milli-Q-purification system (Millipore, Bedford, USA).
Biological matrix
Drug-free rabbit plasma was obtained from Centralized Animal House, Department of Pharmacology and Toxicology, JSS College of Pharmacy (Ooty, Tamil Nadu).
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Chromatographic conditions
Separation was performed using a Shimadzu gradient UFLC system (Shimadzu, Japan) equipped with a diode array detector. The separation was carried out on a reverse phase column SHIMPAC C 18 (250 mm x 4.6 mm i.d, 5µm). The column was operated at 23°C (Ambient temperature). The mobile phase was Isopropyl alcohol/Acetonitrile (50:50 v/v) with a flow rate of 1 ml/min. Detection was carried out in the range 190-600 nm at 269 nm set as a reference wavelength. The injection volume of prepared samples were 20 µl. Lab solutions data station processed the chromatograms. The total runtime per injection was 10 mins. Solutions used were protected from light and maintained at -20°C before analysis.
Preparation of primary stock and working solutions
A 1mg/ml primary stocks of menaquinone-4 and vitamin K 1 (Internal standard) in ethanol were prepared using certified standards. Working solutions with concentrations 100, 10 and 1µg/ml were prepared by appropriately diluting 1mg/ml stock with ethanol.
Preparation of calibration standards
Calibration standards were prepared by serially diluting working solutions to achieve final concentrations of 0.374 -6µg/ml. All internal standard spiked samples were prepared such that the final concentration of internal standard is 5µg/ml.
Preparation of quality control samples
Quality control samples were prepared in concentrations of 4.2µg/ml (HQC), 1.73µg/ml (MQC) and 0.85µg/ml (LQC).
Preparation of plasma samples
Standards were prepared using plasma from the control group of healthy rabbits. Aliquots of plasma were spiked with known amounts of MK-4 and K 1 standard stock solutions ranging from 14.96 -240 µg/ml to obtain working standards ranging from 0.374 -6 µg/ml. A suitable dilution of the stock solution of IS was made and spiked to blank plasma to obtain a final concentration of 5 µg/ml. The spiked plasma samples were stored at -20°C until further analysis. Quality control samples were prepared by spiking the blank plasma samples to obtain 0.85 µg/ml (LQC), 1.73 µg/ ml (MQC) and 4.2 µg/ml (HQC). Menaquinone-4 depleted plasma was prepared by exposing plasma to UV light over 2 hrs.
Sample extraction
Protein precipitation technique was employed for sample extraction. For determination, we used 1.8 ml plasma (Control, calibrator); Sample of 50 µl volume was mixed; 50 µl of internal standard (Vitamin K 1 ) and acetonitrile (100 µl as precipitating agent) were added. The mixture was vortexed for 3 mins and then centrifuged at 5000 rpm for 15 mins. The supernatant was collected for vortexing followed by centrifugation at 5000 rpm for 15 mins. The resulting supernatant was subjected for further analysis in UFLC by taking aliquots of 20µl per injection. We measured plasma samples from albino rabbits. All plasma samples were obtained in tubes with a clot activator (Vacuette, Germany) and the tubes were protected from light, centrifuged 15 mins at 5000 rpm and immediately stored at -80°C. The samples were stored for a maximum of three months before the analysis.
Method validation
Method validation procedures were performed concerning US FDA bioanalytical method validation guideline to evaluate the method suitability for the quantitative determination of menaquinone-4 in rabbit plasma. 
Statistical analysis
Statistical analysis was conducted and data reported as mean ± S.D using MS Excel 2013 (Microsoft Corporation, USA).
RESULTS
Method validation
The real goal of the validation process is to challenge the method and to determine the limits of allowed variability for the conditions needed to run the method. The components of validation methods and procedure adopted for the method validation were presented earlier. This section deals with the discussions of the results obtained.
Linearity
It was observed that the optimized methods were linear within a specific concentration range for MK-4. The calibration curve was plotted between response factor and concentrations of the standard solution ( Figure 3) . The linearity for menaquinone-4 was performed for the spiked plasma at the following concentrations of 0.374, 0.85, 1.73, 3, 4.2, 5.4 and 6µg/ml. The R 2 value was found to be 0.9937.
The calibration curves were constructed on six different days throughout one week to determine the variability of the slopes and intercepts. The results indicated that no significant inter-day variability of slopes and intercepts over the optimized concentration range. (Table 1 )
Accuracy and precision
Relative and absolute recovery experiments determined the accuracy of the optimized method. The percentage recovery values for menaqui- 
Fig
none-4 in plasma ranged from 90.9 to 94.3% and in aqueous solution ranged from 90.6 to 94.4%. It is, therefore, derived that the developed methods are accurate and reliable. The data is given in Table 2 . The optimized methods for the estimation of the drugs were found to be precise. This was evident from the coefficient of variation values, the observed % CV for the developed method is between 3-5 % indicating the developed method to be precise. The results are presented in Table 3 .
The six blank plasma samples were analyzed and the chromatograms were recorded. Endogenous interferences were not detected at the retention time of selected drugs and internal standard. No additional peaks were observed in the sample chromatograms. These peaks, however, did not interfere with the drugs and internal standard peaks. These observations show that the developed assay method is specific and selective and the chromatograms are shown in Figures 4 , 5, 6, 7 and 8. The Retention time of menaquinone-4 is 5.5 ± 0.5 mins and Internal Standard Retention time was 8 ± 0.5 mins, therefore there was no interference between internal standard peak and drug peak.
ranged from 90.6 to 94.4%. It is, therefore, derived that the developed methods are accurate and reliable. The data is given in Table 2 . The optimized methods for the estimation of the drugs were found to be precise. This was evident from the coefficient of variation values, the observed % CV for the developed method is between 3-5 % indicating the developed method to be precise. The results are presented in Table 3 .
The six blank plasma samples were analyzed and the chromatograms were recorded. Endogenous interferences were not detected at the retention time of selected drugs and internal standard. No additional peaks were observed in the sample chromatograms. These peaks, however, did not interfere with the drugs and internal standard peaks. These observations show that the developed assay method is specific and selective and the chromatograms are shown in Figures 4 , 5, 6, 7 and 8.
The Retention time of menaquinone-4 is 5.5 ± 0.5 mins and Internal Standard Retention time was 8 ± 0.5 mins, therefore there was no interference between internal standard peak and drug peak.
Stability
Stability of the sample, standard and reagents used in an HPLC method is required for a reasonable time to generate reproducible and reliable results. Stability of plasma samples spiked with drugs for LQC, MQC and HQC samples were subjected to three freeze-thaw cycles, short-term stability at ambient temperature for 6 hrs and bench top stability at 2-8ºC
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Limit of detection and limit of quantification
The Limit of Detection (LOD) values for menaquinone-4 was found to be 0.187 µg/ml and the Limit of Quantification (LOQ) value was 0.85 µg/ml. This observation in Table 5 showed that the developed methods have adequate sensitivity. These values, however, may be affected by the separation conditions (e.g., column, reagents, instrumentation and data systems), necessary changes (e.g., pumping systems and detectors) and use of non-HPLC grade solvents and may result in changes in signal to noise ratios.
Stability
Stability of the sample, standard and reagents used in an HPLC method is required for a reasonable time to generate reproducible and reliable results. Stability of plasma samples spiked with drugs for LQC, MQC and HQC samples were subjected to three freeze-thaw cycles, short-term stability at ambient temperature for 6 hrs and bench top stability at 2-8ºC for 8 hrs. The stability of these solutions was studied by performing the experiment and looking for changes in separation, retention and asymmetry of the peaks which were then compared with the pattern of the chromatogram of freshly prepared solutions. The stability data is shown in Table 4 . symmetric peaks and peaks without optimal resolution suitable for quantification in plasma. Data on the dietary admission of menaquinones is constrained because of the absence of diet tables that rundown menaquinone-4 fixation in ordinary nourishment. The quantitative analyses of menaquinone-4 till date were done using HPLC-Fluorescence, [11] [12] [13] [14] [15] [16] 13 and human plasma 16 for which a post-column reduction with zinc or zinc added to mobile phase has been used. There is no specified pathway mentioned for post-column derivatization and a comparison of fluorescence detection with other HPLC detections. Retention times of more than 10 mins were observed using HPLC-PDA detection. 17, 19, 22, 24 Mass detection was carried out for samples like human milk, 17 plant extracts, 18 feces, 20 human serum, 20, 22 cell line, 21 human plasma, 22 human osteoblasts 23 and animal milk 24 with menaquinone retention times of 9.8 18 to 30.69 19 mins, which is considered as a disadvantage concerned with the hyphenation. In conclusion, the developed method for the estimation of menaquinone-4 in rabbit plasma is rapid, sensitive, precise, selective and linear and is, therefore, can be employed for a bioequivalence study to evaluate its applicability further.
CONCLUSION
A precise, validated bioanalytical method for the pharmacokinetic evaluation of Menaquinone-4 was developed and validated. Menaquinone-4 was eluted at 5.5 mins, which is an advantage as no other HPLC method has separated this compound below a retention time of 10 mins. This method also consumes less solvent when compared to other HPLC methods as menaquinones-4 is usually separated using nonpolar solvents. Till date, there were no pharmacokinetic studies of menaquinones-4 in rabbits were reported. This method can be applied for the pharmacokinetic study of menaquinones-4 in rabbits and can be further extended to human trials.
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ABBREVIATIONS
Ruggedness and robustness
The ruggedness and robustness of the methods were studied by changing the experimental conditions. No significant changes in the chromatographic parameters were observed when changing the experimental conditions (Operators, the source of reagents and column of similar type) and optimized conditions (pH, mobile phase ratio and flow rate).
System suitability
The System suitability parameters such as column efficiency (Theoretical plates), resolution factor of the optimized methods were found satisfactory and the output is shown in Table 5 . In conclusion, the developed method for the estimation of menaquinone-4 in rabbit plasma was rapid, sensitive, precise, selective, linear and is, therefore, can be employed for a bioequivalence study to evaluate its applicability further.
DISCUSSION
A simple, cost-effective, accurate and fast HPLC method is vital for the routine measurement of menaquinone-4 in plasma and to further study their pharmacokinetics in animal models. This is to correlate their pharmacological effects to plasma levels and pharmacokinetic behavior. In this article, we demonstrate a novel and simple UFLC-DAD method for the quantification of menaquinone-4 in plasma of albino rabbits. To the best of our knowledge, so far, this is the first validated method that offers a simple and fast quantification for menaquinone-4 in rabbit plasma. Optimizing chromatographic conditions was performed using different stationary phases, varying isopropyl alcohol, methanol and acetonitrile compositions and different flow rates. These methods failed to produce 
